Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycaemic response to sulphonylureas as a tool to investigate type 2 diabetes pathophysiology
2007-000594-29Phase 4Terminated
- Sponsor
- NHS Tayside
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of gliclazide in type 2 diabetes mellitus (T2DM), sponsored by NHS Tayside. Primary endpoints: Glycaemic response classification and Phenotypic predictors of sulphonylurea response. Started Feb 2007; status: terminated.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-000594-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000594-29.